Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability

被引:404
作者
Wang, DX
Johnson, AD
Papp, AC
Kroetz, DL
Sadée, W
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Dept Pharmacol, Program Pharmacogenom, Columbus, OH 43210 USA
[2] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
MDR1; ABCB1; single nucleotide polymorphism; allele specific RNA expression; gene expression; mRNA stability; allelic imbalance;
D O I
10.1097/01.fpc.0000178311.02878.83
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives ABCB1 (multidrug resistance 1 polypeptide, MDR1, Pgp) is a multispecific efflux transporter of drugs and xenobiotics. Among numerous polymorphisms in human ABCB1, the synonymous SNP 3435C>T has been associated with decreased mRNA and protein levels, via unknown mechanisms. Methods To search for cis-acting polymorphism affecting transcription or mRNA processing, we used 3435C > T as a marker single nucleotide polymorphism (SNP), for measuring differences in allelic mRNA expression. Ratios of allelic abundance in genomic DNA and mRNA (after conversion to cDNA) were measured quantitatively with a primer extension assay, in human liver samples. Results mRNA expression of the 3435C allele was significantly higher than that of the 3435T allele (3435C/ 3435T ratios ranging from 1.06-1.61). Cotransfection of equal amounts of ABCB1 expression plasmids containing 3435C or 3435T also revealed higher 3435C mRNA expression. Increasing 3435C/3435T ratios after cessation of transcription indicated that the 3435C > T substitution decreases mRNA stability. 3435C>T is in strong linkage disequilibrium with two other coding SNPs (1236C > T and 2677G>T) forming two abundant haplotypes (ABCB1*1 and ABCB1*13). Transfection of all possible combinations of these three SNPs demonstrated that only 3435T is associated with lower mRNA levels. Calculations of mRNA folding, using Mfold, suggested an effect on mRNA secondary structure. Conclusions the abundant 3435C>T SNP appears to be a main factor in allelic variation of ABCB1 mRNA expression in the liver, by changing mRNA stability.
引用
收藏
页码:693 / 704
页数:12
相关论文
共 36 条
[1]   Gene expression and molecular evolution [J].
Akashi, H .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2001, 11 (06) :660-666
[2]   MDR-1 C3435T polymorphism influences cyclosporine A dose requirement in liver-transplant recipients [J].
Bonhomme-Faivre, L ;
Devocelle, A ;
Saliba, F ;
Chatled, S ;
Maccario, J ;
Farinotti, R ;
Picard, V .
TRANSPLANTATION, 2004, 78 (01) :21-25
[3]  
Calado RT, 2002, HAEMATOLOGICA, V87, P564
[4]  
Carlini DB, 2001, GENETICS, V159, P623
[5]   Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor [J].
Duan, JB ;
Wainwright, MS ;
Comeron, JM ;
Saitou, N ;
Sanders, AR ;
Gelernter, J ;
Gejman, PV .
HUMAN MOLECULAR GENETICS, 2003, 12 (03) :205-216
[6]   Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study [J].
Fellay, J ;
Marzolini, C ;
Meaden, ER ;
Back, DJ ;
Buclin, T ;
Chave, JP ;
Decosterd, LA ;
Furrer, H ;
Opravil, M ;
Pantaleo, G ;
Retelska, D ;
Ruiz, L ;
Schinkel, AH ;
Vernazza, P ;
Eap, CB ;
Telenti, A .
LANCET, 2002, 359 (9300) :30-36
[7]   Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution [J].
Gerloff, T .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) :69-77
[8]   Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2 [J].
Goto, M ;
Masuda, S ;
Saito, H ;
Inui, K .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (01) :163-170
[9]   P-glycoprotein and multidrug resistance [J].
Gottesman, MM ;
Pastan, I ;
Ambudkar, SV .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (05) :610-617
[10]   Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1) [J].
Hitzl, M ;
Schaeffeler, E ;
Hocher, B ;
Slowinski, T ;
Halle, H ;
Eichelbaum, M ;
Kaufmann, P ;
Fritz, P ;
Fromm, MF ;
Schwab, M .
PHARMACOGENETICS, 2004, 14 (05) :309-318